Picton Mahoney Asset Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Picton Mahoney Asset Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150,002	Closed	-$1.49M	–	1146
2021 Q4	$1.49M	Buy	150,002 +150,000	+7,500,000%	+$1.49M	0.04%	483
2021 Q3	$1K	Hold	2	–	–	﹤0.01%	875
2021 Q2	$1K	Buy	+2	New	+$20	﹤0.01%	866

Other funds holding EBACU

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Picton Mahoney Asset Management's EBACU Position: Q1 2022 in Review

Picton Mahoney Asset Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2022, closing a stake of 150,002 shares — an estimated $1.49M sold.

Picton Mahoney Asset Management first reported a position in EBACU in Q2 2021 and held it in 3 quarters. The position peaked at $1.49M in Q4 2021. 22 funds tracked by Wall St. Rank hold EBACU as of Q1 2022.

Picton Mahoney Asset Management reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 150,002 European Biotech Acquisition Corp. Units shares in Q1 2022, an estimated $1.49M.
Picton Mahoney Asset Management first reported a position in European Biotech Acquisition Corp. Units in Q2 2021 and held it in 3 quarters.
Picton Mahoney Asset Management's European Biotech Acquisition Corp. Units position peaked at $1.49M in Q4 2021.
22 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2022, filed 11 May 2022.